Search - tctmd.com

Displaying 321 - 340 of 612

Sort: Relevancy | Date

News Daily News

Echo for Acute MI Ups Hospital Stays and Costs, Without Boosting Outcomes

Yael L. Maxwell

June 20, 2019

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

L.A. McKeown

June 20, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Daily News

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

L.A. McKeown

June 19, 2019

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Shelley Wood

June 19, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Daily News

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

Caitlin E. Cox

June 18, 2019

News Daily News

Ischemic Events Worsen Long-term Cognitive Decline

Yael L. Maxwell

June 18, 2019

News Daily News

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

Todd Neale

June 17, 2019

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Shelley Wood

June 17, 2019

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

Presentation TVT 2019

Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

Presenter: Mubashir Mumtaz

June 14, 2019

Presentation TVT 2019

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Presenter: Philippe Pibarot

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

Presentation TVT 2019

Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Meta-Analysis of Randomized Controlled Trials

Presenter: Dhaval Kolte

June 13, 2019

Presentation TVT 2019

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Presenter: Martin Leon

June 13, 2019

News Daily News

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Caitlin E. Cox

June 13, 2019

Presentation TVT 2019

Reactions From the Surgical Community

Presenter: Patrick McCarthy

June 13, 2019

Presentation TVT 2019

Reactions From the Cardiology Community

Presenter: Blase Carabello

June 13, 2019

Advertisement

Echo for Acute MI Ups Hospital Stays and Costs, Without Boosting Outcomes

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

Ischemic Events Worsen Long-term Cognitive Decline

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Meta-Analysis of Randomized Controlled Trials

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Reactions From the Surgical Community

Reactions From the Cardiology Community

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content